Always read the label and follow directions for use. Read the warnings available on nzmsdiabetes.co.nz/resources before purchasing.
Dexcom CGM is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. Tandem t:slim X2 insulin pump with Control-IQ+ provides a continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM. Tandem t:slim X2 insulin pump with Control-IQ+ provides a continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM. *Smart device sold separately. For a list of compatible smart devices, visit dexcom.com/compatibility.
 
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G6, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2026 Dexcom, Inc. All rights reserved. © 2026 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Control-IQ+, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc.
 
New Zealand Medical and Scientific Limited is a Dexcom Company. 2A Fisher Crescent, Mount Wellington, Auckland 1060. MAT-13493.